Home Data Calendar Blog

REGN

Tables

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Weighted Average Number Of Diluted Shares Outstanding 115.40 115.10 NA 113.40 113.90 114.00 NA 112.80 114.00 113.10 NA 113.90 110.80 110.50 NA 113.90 117.90 115.10 NA 114.20 114.60 115.50 NA 115.09 114.48 114.91 NA 117.03 116.14 115.11 NA 116.47 116.23 114.23 NA 115.94 115.26 114.52 NA 117.42 113.03 112.15 NA 116.71 111.06 109.37 NA 115.83 110.17 107.73 NA 91.05 90.44 89.16 NA NA NA NA

Weighted Average Number Of Shares Outstanding Basic 108.10 107.80 NA 106.30 107.00 107.10 NA 106.90 107.90 106.80 NA 106.20 105.00 105.40 NA 105.50 109.60 109.80 NA 109.40 109.20 108.90 NA 108.03 107.80 107.65 NA 106.71 106.03 105.57 NA 104.83 104.63 104.29 NA 103.35 102.89 102.23 NA 100.80 100.39 98.71 NA 98.23 97.70 96.88 NA 95.01 94.59 93.45 NA 91.05 90.44 89.16 NA NA NA NA

Earnings Per Share Basic 13.25 6.70 10.89 9.48 9.05 7.64 11.21 12.31 7.90 9.12 20.98 15.37 29.51 10.58 10.90 7.98 8.19 5.69 7.25 6.12 1.77 4.23 7.58 5.50 5.12 4.44 1.62 3.64 3.66 2.36 2.41 2.53 1.88 1.59 1.49 2.04 1.89 0.74 1.09 0.79 0.92 0.66 0.98 1.44 0.89 1.02 4.92 2.02 0.81 0.12 -0.58 -0.68 -0.69 -0.49 NA NA NA NA

Earnings Per Share Diluted 12.41 6.27 10.20 8.89 8.50 7.17 10.49 11.66 7.47 8.61 19.68 14.33 27.97 10.09 10.24 7.39 7.61 5.43 6.93 5.86 1.68 3.99 7.15 5.17 4.82 4.16 1.50 3.32 3.34 2.16 2.19 2.27 1.69 1.45 1.34 1.82 1.69 0.66 0.96 0.70 0.82 0.58 0.86 1.25 0.79 0.90 4.08 1.72 0.70 0.11 -0.58 -0.68 -0.69 -0.49 NA NA NA NA

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Revenue From Contract With Customer Excluding Assessed Tax 3547.10 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.50 1582.40 1500.67 1470.12 1319.00 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Revenues 3547.10 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.48 1582.45 1500.67 1470.12 1318.99 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Costs And Expenses 2477.50 2393.60 2461.40 2251.70 2141.60 2215.40 2267.60 1712.50 1747.30 1706.60 2312.00 1605.60 1791.30 1416.00 1255.90 1240.90 1295.60 1128.10 1493.80 1309.90 1618.10 1231.80 1209.70 1036.57 985.83 944.25 1043.64 940.75 919.80 888.45 879.82 857.32 921.00 871.54 867.00 745.00 653.76 586.06 586.53 543.07 443.29 439.80 398.34 360.23 299.54 286.61 268.93 225.32 216.92 209.59 168.38 161.29 168.13 153.19 146.45 138.07 139.61 132.41

Research And Development Expense 1200.00 1248.40 1177.20 1075.30 1085.30 1101.20 1043.10 911.30 794.30 843.80 785.60 665.40 714.20 742.90 744.50 684.60 722.00 583.90 683.10 663.40 1048.30 641.80 601.25 556.97 529.29 498.59 527.98 529.75 509.98 507.44 479.21 543.05 559.93 470.11 461.21 425.92 390.33 343.11 351.75 337.73 294.50 287.38 268.14 224.04 187.46 180.30 181.02 158.29 147.37 138.86 129.04 127.92 143.15 129.39 125.21 122.04 124.53 117.47

Selling General And Administrative Expense 758.80 689.00 737.70 640.50 652.00 601.10 660.50 529.10 476.30 450.00 559.60 445.00 414.70 405.60 303.50 326.90 348.30 367.30 586.80 419.90 417.30 410.80 491.31 369.23 364.88 330.77 409.91 306.77 306.91 296.85 325.94 270.05 292.04 289.68 294.95 209.99 174.59 158.99 175.31 149.75 102.41 108.85 82.08 97.61 72.46 77.26 57.74 46.88 47.70 58.43 36.35 32.92 24.59 23.41 20.64 15.66 14.68 14.22

Operating Income Loss 1069.60 751.40 972.90 1111.00 1016.50 946.70 1146.80 1223.70 1109.90 1258.50 2639.70 1847.20 3347.20 1112.70 1167.00 1053.10 656.40 700.10 675.70 738.50 315.60 480.00 718.06 626.92 622.19 567.23 538.81 559.93 550.31 430.54 347.00 362.80 291.63 329.31 231.08 392.42 344.86 283.55 215.80 182.72 222.41 185.94 212.07 236.80 158.10 153.05 145.67 202.36 87.48 22.20 -45.40 -58.46 -60.32 -40.98 -12.78 -32.09 -23.72 -28.88

Interest Expense NA 16.10 18.30 17.80 18.90 18.00 17.40 15.30 13.10 13.60 14.10 14.20 14.40 14.60 14.80 26.30 9.70 6.10 6.70 7.80 8.00 7.70 7.35 7.49 6.92 6.44 6.02 6.18 5.40 7.50 NA NA NA NA 3.61 1.72 2.75 6.17 6.35 9.23 10.18 11.61 11.66 11.74 11.37 11.68 11.49 11.41 11.24 11.16 9.46 4.06 4.05 3.72 2.46 2.23 2.34 2.08

Income Tax Expense Benefit 195.80 -21.30 -12.00 103.00 114.50 40.20 127.60 194.10 111.10 87.60 274.40 184.40 653.90 137.80 75.40 156.20 21.60 44.00 97.80 98.90 31.60 85.00 -144.19 41.21 104.66 107.42 381.25 177.29 138.11 183.36 88.41 101.08 96.04 164.41 72.30 182.89 133.35 200.50 99.63 96.36 110.38 109.82 101.35 84.38 60.32 42.96 -335.80 NA 0.00 NA -0.61 0.56 -0.86 -0.22 0.00 0.00 0.00 0.00

Other Comprehensive Income Loss Net Of Tax 7.30 3.70 NA 20.90 -16.10 57.20 NA -51.30 -53.70 -143.90 NA -6.20 -0.50 -13.10 NA -4.70 44.60 -30.20 NA 0.70 13.00 15.10 NA 1.10 4.10 -9.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Income Loss 1432.30 722.00 1159.60 1007.80 968.40 817.80 1197.10 1315.70 852.10 973.50 2229.00 1632.20 3098.90 1115.20 1149.20 842.10 897.30 624.60 792.00 669.60 193.10 461.10 820.40 594.65 551.41 477.98 173.52 388.32 387.74 248.93 253.12 264.80 196.22 165.74 154.99 210.40 194.64 76.02 110.18 79.72 92.73 65.44 96.81 141.31 87.38 98.87 470.41 191.47 76.74 11.65 -53.44 -62.37 -62.51 -43.45 -14.60 -33.88 -25.47 -30.52

Comprehensive Income Net Of Tax 1439.60 725.70 1255.50 1028.70 952.30 875.00 1233.40 1264.40 798.40 829.60 2193.30 1626.00 3098.40 1102.10 1147.70 837.40 941.90 594.40 796.60 670.30 206.10 476.20 818.62 595.75 555.39 468.34 150.32 409.80 395.98 255.89 243.17 256.70 197.06 161.53 155.84 198.97 165.89 71.67 135.53 102.35 95.53 68.10 98.47 141.88 85.59 98.40 471.14 191.94 75.71 12.18 -53.57 -63.19 -61.23 -43.13 -16.91 -33.74 -26.50 NA

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Assets 36086.80 34369.60 33080.20 32163.30 30657.50 30059.90 29214.50 27677.80 27205.80 26348.70 25434.80 23671.50 21485.90 17772.20 17163.30 16084.00 14428.70 15757.50 14805.20 13939.30 13173.60 12854.80 11734.50 10805.61 9951.98 9372.70 8764.29 8701.22 8106.37 7817.36 6973.47 6828.02 6204.91 5904.46 5609.13 5182.91 4526.97 4198.57 3871.83 3739.42 3456.08 3260.40 2951.01 2640.41 2378.26 2276.00 2080.49 1660.62 1457.50 1350.16 1323.58 983.03 1046.86 1074.29 1089.43 NA NA NA

Liabilities 7881.00 7378.50 7107.10 7258.90 6639.60 6564.70 6550.50 6239.00 6518.00 6434.00 6666.00 6413.50 6358.60 5795.20 6138.00 5958.50 5371.30 3624.50 3715.50 3434.90 3417.70 3410.10 2977.20 2937.31 2765.55 2805.05 2620.21 2649.62 2585.64 2951.34 2524.22 2336.77 2128.40 2139.38 1954.30 1886.05 1188.51 1227.14 1329.50 1187.63 1087.24 1049.15 998.94 950.24 884.92 869.65 835.11 854.59 862.84 846.13 837.85 554.78 568.83 556.20 561.62 NA NA NA

Liabilities And Stockholders Equity 36086.80 34369.60 33080.20 32163.30 30657.50 30059.90 29214.50 27677.80 27205.80 26348.70 25434.80 23671.50 21485.90 17772.20 17163.30 16084.00 14428.70 15757.50 14805.20 13939.30 13173.60 12854.80 11734.50 10805.61 9951.98 9372.70 8764.29 8701.22 8106.37 7817.36 6973.47 6828.02 6204.91 5904.46 5609.13 5182.91 4526.97 4198.57 3871.83 3739.42 3456.08 3260.40 2951.01 2640.41 2378.26 2276.00 2080.49 1660.62 1457.50 1350.16 1323.58 983.03 1046.86 1074.29 1089.43 NA NA NA

Stockholders Equity 28205.80 26991.10 25973.10 24904.40 24017.90 23495.20 22664.00 21438.80 20687.80 19914.70 18768.80 17258.00 15127.30 11977.00 11025.30 10125.50 9057.40 12133.00 11089.70 10504.40 9755.90 9444.70 8757.30 7868.30 7186.43 6567.64 6144.08 6051.59 5520.74 4866.02 4449.24 4491.25 4076.51 3765.08 3654.84 3296.87 3338.46 2971.43 2542.32 2551.79 2368.84 2211.25 1952.08 1690.17 1493.34 1406.35 1245.38 806.02 594.66 504.02 485.73 428.25 478.03 518.09 527.82 348.06 371.22 386.27

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Assets Current 19081.60 18871.50 19479.20 18634.80 16923.00 16909.20 15884.10 15428.60 15529.90 14306.00 14014.90 13775.40 13337.60 10055.10 9779.10 9097.60 7860.20 8644.10 7689.10 7109.10 6651.00 6928.60 6447.60 5719.58 4814.92 4544.73 4335.03 4135.74 3860.05 3669.26 3180.19 3501.69 3209.22 3133.38 2915.09 2675.64 2283.34 2310.71 2167.46 2200.51 1918.69 1871.05 1796.93 1634.16 1561.36 1307.12 1206.01 948.60 769.19 696.91 652.88 339.87 413.27 325.50 357.62 NA NA NA

Cash And Cash Equivalents At Carrying Value 1920.70 2602.00 2730.00 2152.30 1937.20 3916.30 3105.90 3491.30 3395.10 3345.70 2885.60 3432.40 2072.20 1437.90 2193.70 1573.00 1992.20 2208.20 1617.80 1384.80 1045.50 1708.50 1467.70 1087.84 917.88 1019.49 812.73 792.07 744.31 811.77 535.20 920.36 646.51 604.21 809.10 654.59 390.55 507.91 648.72 646.55 600.13 461.86 535.61 263.21 381.68 180.36 230.28 119.00 171.94 394.58 483.61 206.40 254.31 135.38 112.57 325.29 112.00 117.31

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1928.20 2609.80 2737.80 2160.20 1949.70 3928.80 3119.40 3504.80 3408.60 3359.20 2898.10 3444.90 2084.70 1450.40 2207.30 1586.60 2004.70 2220.70 1630.30 1397.30 1058.00 1721.00 1480.20 1100.34 930.38 1031.99 825.23 804.57 756.81 824.27 547.70 NA NA NA 809.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Marketable Securities Current 7888.30 7917.50 8114.80 7761.30 6990.50 5043.40 4636.40 3530.40 4171.30 3704.90 2809.10 2355.20 1838.60 2065.90 1393.30 1452.90 1152.00 1795.20 1596.50 1493.10 1624.20 1523.90 1342.20 1104.31 765.64 605.46 596.85 586.88 523.54 495.31 503.48 488.03 398.66 244.97 236.12 241.06 213.69 234.26 251.76 395.65 216.77 186.28 158.38 182.11 155.83 127.35 77.82 143.55 129.08 37.71 43.33 39.10 55.37 91.06 136.80 NA NA NA

Accounts Receivable Net Current 5717.10 5222.20 5667.30 5584.50 5121.30 5118.60 5328.70 5548.30 5161.40 4839.00 6036.50 5452.00 6998.60 4173.00 3111.50 3092.50 1991.00 2063.10 2100.00 2027.70 1920.20 1728.40 1723.70 1665.74 1534.32 1531.94 1538.64 1532.69 1420.40 1339.79 1343.37 1332.07 1431.97 1450.57 1152.49 1088.21 1071.66 1015.96 739.38 673.91 664.08 801.77 787.07 855.84 767.87 703.86 593.21 506.68 349.64 159.46 28.25 3.66 2.92 3.77 13.51 NA NA NA

Inventory Net 2873.60 2714.90 2580.50 2562.00 2507.70 2424.70 2401.90 2412.20 2218.50 1991.50 1951.30 2053.80 1983.90 2164.70 1916.60 1801.60 1640.90 1480.90 1415.50 1344.30 1317.20 1208.80 1151.20 1039.68 928.55 820.40 726.14 641.59 554.32 466.58 399.36 345.62 316.07 303.29 238.58 190.67 171.27 133.86 128.86 120.32 109.90 86.55 70.35 63.29 57.16 43.98 28.64 29.57 10.50 6.20 3.50 NA NA NA NA NA NA NA

Prepaid Expense And Other Assets Current 681.90 414.90 386.60 574.70 366.30 406.20 411.20 446.40 583.60 424.90 332.40 482.00 444.30 213.60 160.80 230.60 263.80 226.60 387.10 226.90 208.20 182.20 243.30 284.81 163.60 155.45 224.97 143.76 193.33 146.06 130.53 103.81 96.02 115.69 163.50 89.49 43.10 34.10 71.49 61.73 60.67 52.25 96.14 156.84 108.91 97.14 56.66 84.78 32.79 26.27 22.90 15.93 19.03 NA 15.14 NA NA NA

Available For Sale Securities Debt Securities 14436.90 14115.00 12533.90 12620.40 12290.00 10051.30 10018.20 8369.60 9712.10 9750.20 8397.20 6614.90 4337.60 4607.20 3689.10 3550.40 2934.50 4469.60 4234.50 4176.00 4094.80 3733.00 3009.20 2834.21 2724.76 2358.37 2020.56 1826.14 1527.85 1408.36 1318.52 1203.72 917.82 778.76 836.82 894.83 757.16 627.98 613.10 789.56 760.62 717.43 547.10 509.73 326.86 479.53 351.56 461.64 422.99 296.90 322.14 301.33 310.38 NA 510.28 NA NA NA

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Intangible Assets Net Excluding Goodwill 1102.20 1058.70 1038.60 1017.20 953.00 928.70 915.50 804.10 NA NA 6.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Assets Noncurrent 993.80 470.20 444.10 409.90 393.20 349.60 336.40 320.20 269.90 262.00 222.80 145.90 142.90 145.70 168.10 168.80 175.50 161.20 144.70 137.90 139.80 144.30 127.40 125.20 85.67 78.98 77.87 36.62 36.96 37.09 20.29 20.70 6.71 5.79 5.81 4.58 4.14 4.47 3.03 3.42 8.88 5.34 5.33 4.41 15.21 20.08 23.10 18.32 19.57 20.39 19.14 13.02 12.29 10.23 6.79 NA NA NA

Available For Sale Debt Securities Amortized Cost Basis 14524.50 14212.70 12636.00 12843.50 12539.40 10280.80 10320.10 8716.30 9994.40 9965.10 8428.70 6600.90 4315.50 4584.10 3649.20 3508.30 2890.30 4478.00 4206.30 4148.90 4073.70 3730.20 3026.60 2851.52 2743.03 NA 2027.27 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Liabilities Current 3508.60 3580.90 3423.40 3598.60 3104.40 3100.10 3141.30 2879.20 3033.90 3007.60 3932.50 3714.80 3732.40 3217.80 2697.40 2337.80 3702.40 2055.20 2096.60 1765.40 1713.10 1511.40 1442.80 1417.23 1331.19 1265.74 1135.48 1138.63 1029.02 1308.27 1241.49 961.18 951.56 919.72 811.16 734.99 601.54 536.13 654.66 410.20 351.58 305.07 298.83 268.73 203.80 197.24 163.55 178.57 183.22 160.39 148.27 133.24 135.87 112.25 109.06 NA NA NA

Accounts Payable Current 561.70 671.30 606.60 536.60 547.30 599.50 589.20 NA NA NA 564.00 NA NA NA 475.50 NA NA NA 418.10 NA NA NA 218.20 NA NA NA 178.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Accounts Payable And Accrued Liabilities Current NA NA 2357.90 NA NA NA 2074.20 NA NA NA 2206.80 NA NA NA 1521.80 NA NA NA 1086.80 NA NA NA 772.10 NA NA NA 815.08 818.43 716.36 1061.78 879.10 714.92 759.64 733.28 644.11 577.43 529.50 462.76 484.23 337.98 283.38 237.94 250.90 219.14 153.83 145.41 111.34 124.22 126.77 106.72 95.62 78.89 81.67 58.60 53.66 NA NA NA

Other Accrued Liabilities Current NA NA 666.70 NA NA NA 637.50 NA NA NA 383.90 NA NA NA 329.60 NA NA NA 301.30 NA NA NA 164.60 NA NA NA 129.41 84.69 79.37 99.05 103.51 83.46 107.03 102.64 85.64 126.07 72.20 97.88 117.30 55.68 48.54 38.11 29.02 38.32 19.95 22.37 19.57 22.20 15.22 18.20 14.13 8.21 7.81 NA 6.44 NA NA NA

Contract With Customer Liability Current 586.00 516.70 458.90 417.30 381.10 426.30 477.90 547.20 566.30 491.30 442.00 507.80 520.00 464.90 577.70 NA NA NA 591.70 NA NA NA 452.50 NA NA NA 320.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Long Term Debt Noncurrent 1983.60 1983.30 1982.90 1982.60 1982.20 1981.80 1981.40 1981.10 1980.70 1980.40 1980.00 1979.60 1979.20 1978.90 1978.50 1978.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Liabilities Noncurrent 1463.20 908.50 854.10 832.40 716.80 677.30 638.00 598.60 724.70 692.50 680.20 662.60 596.30 571.50 687.10 454.00 457.90 321.50 286.00 273.00 267.90 376.30 361.70 194.03 190.02 169.92 152.07 125.22 115.92 106.25 100.39 135.70 119.52 120.99 115.53 77.91 76.08 55.56 40.85 23.75 14.97 11.79 11.33 10.57 10.20 8.79 7.26 6.99 7.26 7.46 6.44 7.41 6.81 7.18 7.35 NA NA NA

Operating Lease Liability Noncurrent NA NA 68.70 NA NA NA 55.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Stockholders Equity 28205.80 26991.10 25973.10 24904.40 24017.90 23495.20 22664.00 21438.80 20687.80 19914.70 18768.80 17258.00 15127.30 11977.00 11025.30 10125.50 9057.40 12133.00 11089.70 10504.40 9755.90 9444.70 8757.30 7868.30 7186.43 6567.64 6144.08 6051.59 5520.74 4866.02 4449.24 4491.25 4076.51 3765.08 3654.84 3296.87 3338.46 2971.43 2542.32 2551.79 2368.84 2211.25 1952.08 1690.17 1493.34 1406.35 1245.38 806.02 594.66 504.02 485.73 428.25 478.03 518.09 527.82 348.06 371.22 386.27

Additional Paid In Capital 12316.90 11942.60 11354.00 11251.50 10888.50 10597.70 9949.30 9518.20 9120.20 8754.10 8087.50 7919.30 7225.80 6887.80 6716.20 6592.80 6263.00 5211.40 4428.60 4388.40 4263.60 4160.90 3911.60 3841.17 3712.60 3611.60 3512.83 3570.67 3449.62 3190.88 3029.99 3314.98 3156.94 3049.65 3099.53 2880.11 3118.97 2812.57 2404.12 2423.43 2342.84 2236.93 2045.86 1882.42 1827.47 1826.08 1763.51 1795.29 1775.86 1760.94 1754.82 1643.77 1630.36 1609.18 1575.78 NA NA NA

Retained Earnings Accumulated Deficit 29414.60 27982.30 27260.30 26100.70 25092.90 24124.50 23306.70 22109.60 20793.90 19941.80 18968.30 16739.30 15107.10 12008.20 10893.00 9743.80 8901.70 8004.40 7379.80 6587.80 5918.20 5725.10 5254.30 4433.90 3839.18 3287.77 2946.73 2773.21 2384.90 1997.15 1748.22 1495.11 1230.30 1018.44 852.70 697.71 487.31 292.67 255.38 145.21 65.49 -27.25 -92.69 -189.50 -330.80 -418.18 -517.05 -987.46 -1178.93 -1255.67 -1267.32 -1213.88 -1151.52 -1089.01 -1045.56 NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax -69.90 -77.20 -80.90 -176.80 -197.70 -181.60 -238.80 -275.10 -223.80 -170.10 -26.20 9.50 15.70 16.20 29.30 30.80 35.50 -9.10 21.10 16.50 15.80 2.80 -12.30 -10.52 -11.61 -15.59 0.64 23.84 2.35 -5.88 -12.84 -2.90 5.20 4.36 8.57 7.72 19.15 47.90 52.25 26.89 4.26 1.47 -1.19 -2.85 -3.43 -1.64 -1.17 -1.90 -2.37 -1.34 -1.86 -1.73 -0.90 -2.17 -2.49 NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 230.00 233.30 NA 207.40 208.00 237.40 NA 171.10 166.00 165.90 NA 136.40 135.90 135.60 NA 104.60 105.20 108.00 NA 112.70 109.20 114.80 NA 116.50 113.10 85.80 NA NA NA NA NA NA NA NA NA NA NA NA 82.61 74.56 72.16 82.98 55.29 46.08 45.17 53.55 30.67 20.66 19.40 23.45 15.84 13.38 12.49 14.90 NA NA NA 8.83

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Operating Activities 354.00 1512.50 1089.70 1114.30 1022.40 1367.60 1719.90 628.90 564.40 2101.70 2372.50 3413.60 626.70 668.50 1231.00 -254.30 943.40 698.00 787.40 557.30 188.30 897.00 728.83 452.96 394.56 618.74 566.95 414.83 -30.57 355.90 377.88 651.03 415.15 29.34 281.82 892.85 243.61 -87.50 198.28 163.56 327.79 53.53 276.78 92.45 128.16 86.25 93.19 -2.38 -78.38 -87.04 -50.32 -46.73 -34.05 -10.58 -43.73 161.50 -11.85 -9.58

Net Cash Provided By Used In Investing Activities -557.20 -1687.10 -66.20 -496.30 -2386.90 -235.70 -1857.70 192.30 -413.90 -1705.30 -2012.70 -2438.80 125.80 -1059.00 -305.00 -775.80 1453.40 -443.20 -208.70 -207.00 -836.00 -776.10 -265.91 -286.71 -484.97 -425.41 -335.75 -358.88 -170.41 -140.14 -271.36 -405.85 -326.01 -43.69 -123.30 -283.17 -371.65 -129.48 56.65 -123.07 -118.12 -236.23 -109.95 -214.45 116.63 -147.69 91.10 -48.75 -139.19 15.77 -33.91 -0.90 142.94 20.35 -351.74 50.17 3.82 -136.40

Net Cash Provided By Used In Financing Activities -478.10 47.10 -446.10 -407.30 -614.20 -322.50 -247.60 -725.00 -101.10 64.70 -906.60 385.40 -118.20 -366.40 -305.30 612.00 -2612.80 335.60 -345.70 -11.00 -15.30 119.90 -83.03 3.71 -11.21 13.43 -210.53 -8.20 133.52 60.81 -491.68 28.68 -46.84 -190.54 -4.01 -345.65 10.69 76.17 -252.76 5.93 -71.39 108.95 105.56 3.53 -43.48 11.52 -73.01 -1.81 -5.08 -17.75 361.44 -0.28 10.05 13.04 182.76 1.61 2.72 56.22

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Operating Activities 354.00 1512.50 1089.70 1114.30 1022.40 1367.60 1719.90 628.90 564.40 2101.70 2372.50 3413.60 626.70 668.50 1231.00 -254.30 943.40 698.00 787.40 557.30 188.30 897.00 728.83 452.96 394.56 618.74 566.95 414.83 -30.57 355.90 377.88 651.03 415.15 29.34 281.82 892.85 243.61 -87.50 198.28 163.56 327.79 53.53 276.78 92.45 128.16 86.25 93.19 -2.38 -78.38 -87.04 -50.32 -46.73 -34.05 -10.58 -43.73 161.50 -11.85 -9.58

Net Income Loss 1432.30 722.00 1159.60 1007.80 968.40 817.80 1197.10 1315.70 852.10 973.50 2229.00 1632.20 3098.90 1115.20 1149.20 842.10 897.30 624.60 792.00 669.60 193.10 461.10 820.40 594.65 551.41 477.98 173.52 388.32 387.74 248.93 253.12 264.80 196.22 165.74 154.99 210.40 194.64 76.02 110.18 79.72 92.73 65.44 96.81 141.31 87.38 98.87 470.41 191.47 76.74 11.65 -53.44 -62.37 -62.51 -43.45 -14.60 -33.88 -25.47 -30.52

Depreciation Depletion And Amortization 120.70 114.10 113.00 105.40 103.10 99.50 100.10 92.60 74.40 74.30 74.50 73.20 71.10 67.40 61.70 59.30 58.80 56.10 54.30 52.90 52.10 51.00 42.76 35.44 33.64 36.36 34.51 37.72 35.13 38.12 28.90 27.84 25.03 22.98 22.91 20.67 15.30 16.03 14.13 14.01 13.02 11.53 11.29 10.80 9.70 9.41 9.78 9.33 9.42 8.42 7.94 8.28 7.90 6.98 6.09 4.89 4.52 4.18

Increase Decrease In Accounts Receivable 494.10 -446.80 82.70 463.50 2.70 -210.10 -219.60 386.90 322.40 -1197.50 584.50 -1541.00 2825.60 58.30 80.80 1228.20 -121.90 169.00 12.20 204.10 150.70 106.10 40.30 163.70 95.31 -30.41 2.89 126.90 95.00 137.93 -32.25 -108.10 -113.25 397.43 28.48 44.19 97.69 321.06 90.14 33.33 -153.57 92.53 -101.05 116.81 73.38 109.52 91.85 165.89 197.03 135.31 35.78 -6.12 -3.59 -4.96 10.82 -12.91 23.34 6.29

Increase Decrease In Inventories 181.80 155.80 47.30 77.20 100.40 46.80 144.30 223.50 240.10 88.60 163.70 109.10 -31.30 252.80 127.00 169.00 162.60 70.80 108.30 59.00 109.60 58.60 106.28 99.52 93.34 88.76 78.55 84.10 81.80 69.74 50.07 26.82 10.62 62.26 30.37 31.61 43.92 5.93 9.98 13.62 21.75 15.55 11.21 5.60 13.56 17.58 NA NA NA NA NA NA NA NA NA NA NA NA

Share Based Compensation 223.20 230.10 240.40 203.90 202.00 238.70 232.00 166.30 159.80 166.90 188.40 136.90 145.50 130.90 121.50 101.20 103.50 105.80 133.50 117.10 105.80 107.90 126.75 111.44 106.80 82.42 127.13 125.10 121.26 133.79 154.56 131.38 131.69 142.25 158.39 102.60 94.26 103.76 81.45 68.10 64.83 81.41 55.18 45.74 44.44 53.03 30.77 20.54 19.61 23.24 15.53 13.36 12.40 14.80 13.57 8.79 8.71 8.83

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Investing Activities -557.20 -1687.10 -66.20 -496.30 -2386.90 -235.70 -1857.70 192.30 -413.90 -1705.30 -2012.70 -2438.80 125.80 -1059.00 -305.00 -775.80 1453.40 -443.20 -208.70 -207.00 -836.00 -776.10 -265.91 -286.71 -484.97 -425.41 -335.75 -358.88 -170.41 -140.14 -271.36 -405.85 -326.01 -43.69 -123.30 -283.17 -371.65 -129.48 56.65 -123.07 -118.12 -236.23 -109.95 -214.45 116.63 -147.69 91.10 -48.75 -139.19 15.77 -33.91 -0.90 142.94 20.35 -351.74 50.17 3.82 -136.40

Payments To Acquire Productive Assets 180.50 133.90 251.40 176.00 113.00 178.20 152.20 142.50 153.60 141.80 154.90 133.20 148.50 115.30 161.40 153.20 129.90 170.10 139.00 121.70 94.60 74.30 85.46 106.25 112.02 79.38 107.66 59.65 54.85 50.46 150.46 118.56 138.84 104.09 177.78 146.10 239.89 114.16 117.54 79.77 70.87 64.82 68.98 31.69 34.45 21.20 15.16 10.25 12.87 11.05 11.29 8.90 14.86 22.17 32.26 22.10 22.58 22.74

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Net Cash Provided By Used In Financing Activities -478.10 47.10 -446.10 -407.30 -614.20 -322.50 -247.60 -725.00 -101.10 64.70 -906.60 385.40 -118.20 -366.40 -305.30 612.00 -2612.80 335.60 -345.70 -11.00 -15.30 119.90 -83.03 3.71 -11.21 13.43 -210.53 -8.20 133.52 60.81 -491.68 28.68 -46.84 -190.54 -4.01 -345.65 10.69 76.17 -252.76 5.93 -71.39 108.95 105.56 3.53 -43.48 11.52 -73.01 -1.81 -5.08 -17.75 361.44 -0.28 10.05 13.04 182.76 1.61 2.72 56.22

Payments For Repurchase Of Common Stock 603.90 291.30 289.00 546.50 688.80 710.70 431.10 934.60 359.00 358.10 866.90 166.40 305.20 306.90 381.10 92.10 5052.90 320.70 246.50 19.40 0.00 10.00 0.02 4.38 0.00 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31

Revenues 3547.10 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.48 1582.45 1500.67 1470.12 1318.99 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Revenue From Contract With Customer Excluding Assessed Tax 3547.10 3145.00 3434.30 3362.70 3158.10 3162.10 3414.40 2936.20 2857.20 2965.10 4951.70 3452.80 5138.50 2528.70 2422.90 2294.00 1952.00 1828.20 2169.50 2048.40 1933.70 1711.80 1927.80 1663.50 1608.02 1511.50 1582.40 1500.67 1470.12 1319.00 1226.83 1220.12 1212.63 1200.85 1098.08 1137.42 998.62 869.61 802.33 725.79 665.70 625.74 610.41 597.03 457.64 439.66 414.60 427.69 304.40 231.79 122.98 102.83 107.81 112.20 133.68 105.98 115.89 103.53

Collaboration Revenue 1524.00 1266.80 1370.00 1438.30 1316.70 1378.10 -1268.30 1050.60 1043.60 1232.50 -1011.90 1073.90 954.70 754.40 -508.70 653.20 513.30 528.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Inmazeb 0.00 1.00 NA NA 2.20 2.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

L I B T A Y O Net Product Sales 297.40 263.90 NA NA 210.00 176.90 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Product 1918.60 1761.30 1851.80 1786.10 1772.10 1668.00 1699.30 1801.40 1754.40 1638.60 3975.20 2279.90 4137.80 1724.30 1621.80 1482.20 1226.90 1236.70 1286.40 1238.30 1205.30 1104.40 1096.42 1025.49 996.38 987.90 978.75 957.37 924.13 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Product And Service Other 104.50 116.90 212.50 138.30 69.30 116.00 127.70 84.20 59.20 94.00 86.20 99.00 46.00 50.00 123.40 158.60 211.80 63.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other, Roche Collaboration Agreement, Collaboration Revenue NA NA -3.80 -5.70 -3.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement For Manufacturing Of Commercial Supplies, Sanofi Collaboration Agreement Antibody, Collaboration Revenue 157.30 105.80 107.00 151.50 192.60 161.90 166.90 160.50 145.50 160.80 127.60 144.70 110.90 105.60 93.00 94.30 100.60 80.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement Of Commercialization Related Expenses, Sanofi Collaboration Agreement Antibody, Selling General And Administrative Expenses 150.80 139.50 150.40 135.50 130.90 117.60 126.30 108.60 110.80 91.70 103.60 79.00 78.30 60.40 99.00 83.20 86.00 91.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement Of Research And Development Expenses Net Of Obligation For Share Of R D Expenses, Sanofi Collaboration Agreement Antibody, Research And Development Expense -9.10 -18.60 -17.00 -25.80 -14.50 -26.40 -16.60 -4.30 37.10 26.80 39.70 34.90 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Ronapreve, Roche Collaboration Agreement, Collaboration Revenue 0.40 0.50 2.10 0.00 0.00 222.20 396.40 6.40 8.20 216.30 0.00 127.10 167.90 66.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Sales Based Milestone Earned, Sanofi Collaboration Agreement Antibody, Collaboration Revenue NA NA 0.00 50.00 NA NA 50.00 0.00 0.00 50.00 0.00 50.00 NA NA 0.00 50.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Share Of Profit Losses, Sanofi Collaboration Agreement Antibody, Collaboration Revenue 988.30 NA NA NA 751.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Share Of Profit Losses In Connection With Commercialization, Sanofi Collaboration Agreement Antibody, Collaboration Revenue NA 804.00 NA 863.00 751.10 636.50 NA 551.10 496.60 415.30 NA 387.00 327.60 260.60 NA 212.80 171.90 170.90 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

ELYEAHD,US 304.20 200.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

E L Y E A H D And E Y L E A,US 1534.70 1401.60 NA NA 1500.10 1433.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Evkeeza,US 30.40 24.80 24.00 19.10 19.30 14.90 15.40 13.60 11.10 8.50 9.30 6.60 2.00 0.50 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Eylea Net Product Sales,US 1230.50 1201.60 1337.50 1448.20 1500.10 1433.80 1496.40 1629.40 1621.20 1517.60 1547.20 1473.40 1424.70 1347.00 1343.20 1318.30 1113.70 1172.00 1222.10 1187.70 1160.30 1074.10 1078.87 1021.78 992.00 984.00 974.77 953.28 919.47 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Inmazeb,US NA NA 62.10 3.30 2.20 2.20 0.00 3.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

L I B T A Y O Net Product Sales,US 182.40 159.20 154.80 144.10 130.20 109.70 110.00 94.70 90.90 78.90 80.80 78.40 78.00 69.10 74.10 71.60 63.30 61.70 60.50 47.60 40.80 26.80 14.80 0.00 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

L I B T A Y O Net Product Sales, Non Us 115.00 104.70 NA NA 79.80 67.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Praluent Net Product Sales,US 56.10 70.00 61.30 40.40 40.50 40.20 35.50 29.70 31.20 33.60 40.00 44.80 41.90 43.30 55.20 48.50 47.20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Profit In Connection With Commercialization, Non Us, Bayer Collaboration Agreement, Collaboration Revenue NA 333.90 345.40 349.90 349.50 331.60 324.00 315.30 339.70 338.40 353.90 351.00 335.40 308.90 335.30 287.90 230.90 253.80 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Regenerons Obligation Of Research And Development Expenses Net Of Reimbursement Of Research And Development Expenses, Non Us, Bayer Collaboration Agreement, Research And Development Expenses And Reduction Of Research And Development Expense -14.70 -8.70 -8.90 -9.70 -12.00 -13.40 6.40 7.10 2.90 0.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Reimbursement For Manufacturing Of Commercial Supplies, Non Us, Bayer Collaboration Agreement, Collaboration Revenue 22.10 22.10 31.40 27.20 27.20 25.30 31.10 17.50 17.80 25.00 18.50 14.00 13.70 13.90 25.30 12.00 13.30 27.60 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Share Of Profit Losses, Non Us, Bayer Collaboration Agreement, Collaboration Revenue 353.00 NA NA NA 349.50 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Plots across concepts

IncomeStatement

Other Comprehensive Income Loss Net Of Tax

Expenses

Interest Expense

Balance Sheet

Operating Lease Right Of Use Asset

Assets

Operating Lease Right Of Use Asset

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Operating Lease Right Of Use Asset

Liabilities

Operating Lease Liability

Current Liabilities

Operating Lease Liability Current

Noncurrent Liabilities

Operating Lease Liability Noncurrent

Stockholders Equity

Accumulated Other Comprehensive Income Loss Net Of Tax

CashFlow

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInOperatingActivities

Increase Decrease In Inventories

NetCashProvidedByUsedInInvestingActivities

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInFinancingActivities

Net Cash Provided By Used In Financing Activities

Shares

Weighted Average Number Of Shares Outstanding Basic

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Interest Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Payments Due Year Four

FiniteLivedIntangibleAssets

Finite Lived Intangible Assets Accumulated Amortization

InventoryNet

Inventory Finished Goods Net Of Reserves

Line plots across dimensions of each concept